Description of a French Population of Diabetics Treated Followed up by General Practitioners

Stud Health Technol Inform. 2023 May 18:302:856-860. doi: 10.3233/SHTI230289.

Abstract

In France, the prevalence of treated diabetes has been estimated at 4.6%, or more than 3 million people and 5.2% in Northern France. The reuse of primary care data allows to study outpatient clinical data such as laboratory results and drug prescriptions, which are not documented in claims and hospital databases. In this study, we selected the population of treated diabetics from the Wattrelos primary care data warehouse, in North of France. Firstly, we studied the laboratory results of diabetics by identifying whether the recommendations of the French National Authority for Health (HAS) were respected. In a second step, we studied the prescriptions of diabetics by identifying the oral hypoglycemic agents treatments and insulins treatments. The diabetic population represents 690 patients of the health care center. The recommendations on labortatory are respected for 84% of diabetics. The majority of diabetics are treated with oral hypoglycemic agents 68.6%. As recommended by the HAS, metformin is the first-line treatment in the diabetic population.

Keywords: Diabetes mellitus; data reuse; general practitioner; primary care.

MeSH terms

  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetes Mellitus, Type 2* / epidemiology
  • Drug Prescriptions
  • France / epidemiology
  • General Practitioners*
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Metformin* / therapeutic use

Substances

  • Hypoglycemic Agents
  • Metformin